Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1988
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2002 4
2003 1
2005 2
2006 2
2007 2
2008 4
2009 3
2010 4
2011 10
2012 5
2013 7
2014 8
2015 10
2016 9
2017 1
2018 7
2019 8
2020 13
2021 14
2022 11
2023 17
2024 19
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society. Emile JF, et al. Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10. Blood. 2016. PMID: 26966089 Free PMC article. Review.
This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage …
This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) …
Macrophage Activation Syndrome.
Ravelli A, Davì S, Minoia F, Martini A, Cron RQ. Ravelli A, et al. Hematol Oncol Clin North Am. 2015 Oct;29(5):927-41. doi: 10.1016/j.hoc.2015.06.010. Epub 2015 Aug 25. Hematol Oncol Clin North Am. 2015. PMID: 26461152 Free article. Review.
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
Keenan C, Nichols KE, Albeituni S. Keenan C, et al. Front Immunol. 2021 Feb 16;12:614704. doi: 10.3389/fimmu.2021.614704. eCollection 2021. Front Immunol. 2021. PMID: 33664745 Free PMC article. Review.
Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome driven by overactive T cells and macrophages that abundantly secrete numerous pro-inflammatory cytokines, including interferon (IFN)-gamma, interleukin (IL)-1-beta, IL-2, IL-6, IL-10, IL-1
Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome driven by overactive T cells and macrophages tha
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination.
Iba T, Levy JH. Iba T, et al. Trends Cardiovasc Med. 2022 Jul;32(5):249-256. doi: 10.1016/j.tcm.2022.02.008. Epub 2022 Feb 22. Trends Cardiovasc Med. 2022. PMID: 35202800 Free PMC article. Review.
If anti-PF4 ELISA is not available, discriminating other conditions such as antiphospholipid syndrome, thrombotic thrombocytopenic purpura, immune thrombocytopenic purpura, systemic lupus erythematosus, and hemophagocytic syndrome/hemophagocytic lymphohistiocytos
If anti-PF4 ELISA is not available, discriminating other conditions such as antiphospholipid syndrome, thrombotic thrombocytopenic purpura, …
Clinical characteristics of severe neonatal enterovirus infection: a systematic review.
Zhang M, Wang H, Tang J, He Y, Xiong T, Li W, Qu Y, Mu D. Zhang M, et al. BMC Pediatr. 2021 Mar 15;21(1):127. doi: 10.1186/s12887-021-02599-y. BMC Pediatr. 2021. PMID: 33722228 Free PMC article.
Among them, 46.0% neonates had hepatitis or coagulopathy, 37.1% had myocarditis, 11.0% had meningoencephalitis, and 5.9% had other complications such as hemophagocytic lymphohistiocytosis and pulmonary hemorrhage. ...The most common symptoms included temperat …
Among them, 46.0% neonates had hepatitis or coagulopathy, 37.1% had myocarditis, 11.0% had meningoencephalitis, and 5.9% had other co …
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies.
Freyer CW, Porter DL. Freyer CW, et al. J Allergy Clin Immunol. 2020 Nov;146(5):940-948. doi: 10.1016/j.jaci.2020.07.025. Epub 2020 Aug 6. J Allergy Clin Immunol. 2020. PMID: 32771558 Review.
Patients with severe CRS may develop capillary leak syndrome and disseminated intravascular coagulation, with a cytokine signature similar to that of macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Moderate-to-severe CRS is managed with the IL-6 r …
Patients with severe CRS may develop capillary leak syndrome and disseminated intravascular coagulation, with a cytokine signature similar t …
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy.
Cordas Dos Santos DM, Tix T, Shouval R, Gafter-Gvili A, Alberge JB, Cliff ERS, Theurich S, von Bergwelt-Baildon M, Ghobrial IM, Subklewe M, Perales MA, Rejeski K. Cordas Dos Santos DM, et al. Nat Med. 2024 Sep;30(9):2667-2678. doi: 10.1038/s41591-024-03084-6. Epub 2024 Jul 8. Nat Med. 2024. PMID: 38977912
NRM point estimates varied across disease entities and were highest in patients with mantle-cell lymphoma (10.6%), followed by multiple myeloma (8.0%), large B cell lymphoma (6.1%) and indolent lymphoma (5.7%). Entity-specific meta-regression models for large B cell lympho …
NRM point estimates varied across disease entities and were highest in patients with mantle-cell lymphoma (10.6%), followed by multiple myel …
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.
Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Rosée P, Birndt S. Knauft J, et al. Leukemia. 2024 Feb;38(2):235-249. doi: 10.1038/s41375-024-02135-8. Epub 2024 Jan 18. Leukemia. 2024. PMID: 38238443 Free PMC article. Review.
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome driven by pathologic activation of cytotoxic T-lymphocytes and macrophages. ...The majority of patients (91.6%) presented in Ann-Arbor-Stages III and IV, and bone marrow infiltration was
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome driven by pathologic activation of cytotoxic T
Familial Hemophagocytic Lymphohistiocytosis.
Degar B. Degar B. Hematol Oncol Clin North Am. 2015 Oct;29(5):903-13. doi: 10.1016/j.hoc.2015.06.008. Epub 2015 Aug 25. Hematol Oncol Clin North Am. 2015. PMID: 26461150 Review.
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare heritable disorder of immune regulation that is typically characterized by sudden onset of severe systemic illness. ...
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare heritable disorder of immune regulation that is typically c
Macrophage activation syndrome in the era of biologic therapy.
Grom AA, Horne A, De Benedetti F. Grom AA, et al. Nat Rev Rheumatol. 2016 May;12(5):259-68. doi: 10.1038/nrrheum.2015.179. Epub 2016 Mar 24. Nat Rev Rheumatol. 2016. PMID: 27009539 Free PMC article. Review.
Although increasingly recognized as a life-threatening complication of various rheumatic diseases, clinically, MAS is strikingly similar to primary and secondary forms of haemophagocytic lymphohistiocytosis (HLH). Not surprisingly, many rheumatologists prefer the term seco …
Although increasingly recognized as a life-threatening complication of various rheumatic diseases, clinically, MAS is strikingly similar to …
146 results